Skip to main content

George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals | EurekAlert! Science News

By July 29, 2019News
bhi-george-mason-gmu-logo

bhi-george-mason-gmu-logo

A patent granted to George Mason University Research Foundation Inc., which describes a novel treatment method for pre-invasive breast cancer, has been exclusively licensed to Targeted Pharmaceuticals LLC, a clinical-stage biopharmaceutical company focused on utilizing cannabinoids for the treatment of oncology and central nervous system disorders.

{iframe}https://www.eurekalert.org/pub_releases/2019-07/gmu-gmu072319.php{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.